Abingworth Llp decreased its stake in Cymabay (CBAY) by 25.65% based on its latest 2017Q4 regulatory filing with the SEC. Abingworth Llp sold 395,645 shares as the company’s stock rose 28.89% while stock markets declined. The institutional investor held 1.15 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $10.55M, down from 1.54 million at the end of the previous reported quarter. Abingworth Llp who had been investing in Cymabay for a number of months, seems to be less bullish one the $756.94M market cap company. The stock increased 2.63% or $0.33 during the last trading session, reaching $12.88. About 390,584 shares traded. CymaBay Therapeutics, Inc. (NASDAQ:CBAY) has risen 197.77% since May 20, 2017 and is uptrending. It has outperformed by 186.22% the S&P500.
Jonathan Lourie increased its stake in Time Warner Inc (TWX) by 15400.76% based on its latest 2017Q4 regulatory filing with the SEC. Cheyne Capital Management Uk Llp bought 261,813 shares as the company’s stock rose 1.97% while stock markets declined. The hedge fund run by Jonathan Lourie held 263,513 shares of the television services company at the end of 2017Q4, valued at $24.14 million, up from 1,700 at the end of the previous reported quarter. Cheyne Capital Management Uk Llp who had been investing in Time Warner Inc for a number of months, seems to be bullish on the $73.89B market cap company. The stock increased 1.69% or $1.57 during the last trading session, reaching $94.45. About 8.72M shares traded or 67.82% up from the average. Time Warner Inc. (NYSE:TWX) has declined 3.25% since May 20, 2017 and is downtrending. It has underperformed by 14.80% the S&P500.
More notable recent Time Warner Inc. (NYSE:TWX) news were published by: Seekingalpha.com which released: “AT&T conference update: Network speed investment, streaming video upgrades” on May 15, 2018, also Finance.Yahoo.com with their article: “Time Warner Inc Stock Appears to Have Nothing But Upside” published on April 23, 2018, Seekingalpha.com published: “AT&T opposes divestitures in TWX deal” on May 04, 2018. More interesting news about Time Warner Inc. (NYSE:TWX) were released by: Benzinga.com and their article: “Jefferies: The Fate Of Fox Depends On The AT&T-Time Warner Merger Trial” published on May 08, 2018 as well as Seekingalpha.com‘s news article titled: “Corvex adds ServiceNow, exits Comcast in Q1” with publication date: May 15, 2018.
Among 41 analysts covering Time Warner Inc. (NYSE:TWX), 18 have Buy rating, 0 Sell and 23 Hold. Therefore 44% are positive. Time Warner Inc. had 126 analyst reports since August 6, 2015 according to SRatingsIntel. As per Thursday, March 2, the company rating was downgraded by Loop Capital. The firm has “Overweight” rating given on Monday, April 11 by JP Morgan. The firm earned “Neutral” rating on Monday, October 24 by Macquarie Research. FBR Capital maintained the shares of TWX in report on Thursday, December 22 with “Outperform” rating. The stock of Time Warner Inc. (NYSE:TWX) earned “Outperform” rating by Credit Agricole on Thursday, November 5. RBC Capital Markets maintained it with “Hold” rating and $108.0 target in Thursday, February 1 report. The stock has “Neutral” rating by Goldman Sachs on Monday, October 24. The stock has “Outperform” rating by Barrington Research on Friday, November 6. Moffett Nathanson downgraded Time Warner Inc. (NYSE:TWX) on Monday, October 24 to “Neutral” rating. Barclays Capital maintained Time Warner Inc. (NYSE:TWX) rating on Friday, November 13. Barclays Capital has “Equal-Weight” rating and $80 target.
Investors sentiment increased to 0.91 in Q4 2017. Its up 0.15, from 0.76 in 2017Q3. It increased, as 64 investors sold TWX shares while 363 reduced holdings. 122 funds opened positions while 265 raised stakes. 598.25 million shares or 1.97% more from 586.69 million shares in 2017Q3 were reported. Hartford Inv Mngmt stated it has 161,213 shares. Allsquare Wealth Ltd Com stated it has 0.03% of its portfolio in Time Warner Inc. (NYSE:TWX). Legal & General Grp Incorporated Pcl invested in 0.26% or 3.90M shares. Banced Corp holds 0.8% or 5,299 shares in its portfolio. Capital Int owns 396,900 shares or 0.04% of their US portfolio. Bnp Paribas Arbitrage owns 0.04% invested in Time Warner Inc. (NYSE:TWX) for 254,840 shares. Brave Asset has 1,433 shares. Benjamin F Edwards Communications Inc holds 0.07% or 6,815 shares. Moreover, Water Island Lc has 5.35% invested in Time Warner Inc. (NYSE:TWX). Axa holds 203,275 shares. New Mexico Educational Retirement Board accumulated 74,803 shares. Wealthtrust Axiom Ltd Com invested in 0.78% or 23,007 shares. Integral Derivatives Llc holds 0.03% in Time Warner Inc. (NYSE:TWX) or 16,142 shares. Metropolitan Life Ins Com has 0.15% invested in Time Warner Inc. (NYSE:TWX) for 120,553 shares. New Jersey Better Educational Savings reported 18,000 shares stake.
Since December 14, 2017, it had 0 insider purchases, and 3 insider sales for $2.88 million activity. Shares for $390,647 were sold by BARR WILLIAM P on Monday, February 5. $376,219 worth of Time Warner Inc. (NYSE:TWX) shares were sold by WRIGHT DEBORAH C.
Cheyne Capital Management Uk Llp, which manages about $8.62 billion and $229.68 million US Long portfolio, decreased its stake in Nxstage Medical Inc (NASDAQ:NXTM) by 223,412 shares to 190,000 shares, valued at $4.61M in 2017Q4, according to the filing. It also reduced its holding in Akorn Inc (NASDAQ:AKRX) by 438,846 shares in the quarter, leaving it with 561,154 shares, and cut its stake in Molina Healthcare Inc (Prn).
Analysts await CymaBay Therapeutics, Inc. (NASDAQ:CBAY) to report earnings on August, 9. They expect $-0.23 earnings per share, up 25.81% or $0.08 from last year’s $-0.31 per share. After $-0.32 actual earnings per share reported by CymaBay Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -28.13% EPS growth.
Among 8 analysts covering Cymabay Therapeutics Inc (NASDAQ:CBAY), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cymabay Therapeutics Inc had 31 analyst reports since July 21, 2015 according to SRatingsIntel. H.C. Wainwright initiated the stock with “Buy” rating in Wednesday, March 28 report. The stock has “Buy” rating by Piper Jaffray on Wednesday, January 31. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, March 30 report. Piper Jaffray maintained CymaBay Therapeutics, Inc. (NASDAQ:CBAY) on Tuesday, July 25 with “Buy” rating. The firm earned “Buy” rating on Tuesday, September 8 by H.C. Wainwright. The company was initiated on Friday, July 1 by Roth Capital. The company was downgraded on Wednesday, June 1 by H.C. Wainwright. Piper Jaffray initiated CymaBay Therapeutics, Inc. (NASDAQ:CBAY) on Tuesday, July 21 with “Overweight” rating. The stock of CymaBay Therapeutics, Inc. (NASDAQ:CBAY) has “Buy” rating given on Monday, April 16 by Roth Capital. The firm has “Buy” rating by Leerink Swann given on Wednesday, March 28.